dc.contributor.author | Serra, V. | |
dc.contributor.author | Eichhorn, Pieter | |
dc.contributor.author | García-García, C. | |
dc.contributor.author | Ibrahim, Y. | |
dc.contributor.author | Prudkin, L. | |
dc.contributor.author | Sánchez, G. | |
dc.contributor.author | Rodríguez, O. | |
dc.contributor.author | Antón, P. | |
dc.contributor.author | Parra, J. | |
dc.contributor.author | Marlow, S. | |
dc.contributor.author | Scaltriti, M. | |
dc.contributor.author | Pérez-Garcia, J. | |
dc.contributor.author | Prat, A. | |
dc.contributor.author | Arribas, J. | |
dc.contributor.author | Hahn, W. | |
dc.contributor.author | Kim, S. | |
dc.contributor.author | Baselga, J. | |
dc.date.accessioned | 2018-12-13T09:09:13Z | |
dc.date.available | 2018-12-13T09:09:13Z | |
dc.date.created | 2018-12-12T02:47:09Z | |
dc.date.issued | 2014 | |
dc.identifier.citation | Serra, V. and Eichhorn, P. and García-García, C. and Ibrahim, Y. and Prudkin, L. and Sánchez, G. and Rodríguez, O. et al. 2014. Erratum: RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer (Journal of Clinical Investigation (2013) 123:6 (2551-2563) DOI:10.1172/JCI66343). Journal of Clinical Investigation. 124 (3). | |
dc.identifier.uri | http://hdl.handle.net/20.500.11937/71201 | |
dc.identifier.doi | 10.1172/JCI75534 | |
dc.publisher | American Society for Clinical Investigation | |
dc.title | Erratum: RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer (Journal of Clinical Investigation (2013) 123:6 (2551-2563) DOI:10.1172/JCI66343) | |
dc.type | Journal Article | |
dcterms.source.volume | 124 | |
dcterms.source.number | 3 | |
dcterms.source.issn | 0021-9738 | |
dcterms.source.title | Journal of Clinical Investigation | |
curtin.department | School of Pharmacy and Biomedical Sciences | |
curtin.accessStatus | Fulltext not available | |